Contemporary Perspective on Endogenous Myocardial Regeneration
Overview
Authors
Affiliations
Considering the complex nature of the adult heart, it is no wonder that innate regenerative processes, while maintaining adequate cardiac function, fall short in myocardial jeopardy. In spite of these enchaining limitations, cardiac rejuvenation occurs as well as restricted regeneration. In this review, the background as well as potential mechanisms of endogenous myocardial regeneration are summarized. We present and analyze the available evidence in three subsequent steps. First, we examine the experimental research data that provide insights into the mechanisms and origins of the replicating cardiac myocytes, including cell populations referred to as cardiac progenitor cells (i.e., c-kit+ cells). Second, we describe the role of clinical settings such as acute or chronic myocardial ischemia, as initiators of pathways of endogenous myocardial regeneration. Third, the hitherto conducted clinical studies that examined different approaches of initiating endogenous myocardial regeneration in failing human hearts are analyzed. In conclusion, we present the evidence in support of the notion that regaining cardiac function beyond cellular replacement of dysfunctional myocardium via initiation of innate regenerative pathways could create a new perspective and a paradigm change in heart failure therapeutics. Reinitiating cardiac morphogenesis by reintroducing developmental pathways in the adult failing heart might provide a feasible way of tissue regeneration. Based on our hypothesis "embryonic recall", we present first supporting evidence on regenerative impulses in the myocardium, as induced by developmental processes.
Progressive Reinvention or Destination Lost? Half a Century of Cardiovascular Tissue Engineering.
Zilla P, Deutsch M, Bezuidenhout D, Davies N, Pennel T Front Cardiovasc Med. 2020; 7:159.
PMID: 33033720 PMC: 7509093. DOI: 10.3389/fcvm.2020.00159.
Circular RNA (circRNA) CDYL Induces Myocardial Regeneration by ceRNA After Myocardial Infarction.
Zhang M, Wang Z, Cheng Q, Wang Z, Lv X, Wang Z Med Sci Monit. 2020; 26:e923188.
PMID: 32522972 PMC: 7304314. DOI: 10.12659/MSM.923188.
Morrissette-McAlmon J, Ginn B, Somers S, Fukunishi T, Thanitcul C, Rindone A Sci Rep. 2020; 10(1):8387.
PMID: 32433563 PMC: 7239907. DOI: 10.1038/s41598-020-65064-3.
Kaur G, Cai C Stem Cells Int. 2018; 2018:9308301.
PMID: 29760740 PMC: 5926481. DOI: 10.1155/2018/9308301.
Chen Z, Xie J, Hao H, Lin H, Wang L, Zhang Y Cardiovasc Res. 2017; 113(6):620-632.
PMID: 28453729 PMC: 5412017. DOI: 10.1093/cvr/cvx001.